PAVmed Total Assets from 2010 to 2024

PAVMZ Stock

USD 0.01 0.0001 0.66%

PAVmed Series Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets will likely drop to about 23.6 M in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2015-03-31

Previous Quarter

39.4 M

Current Value

30.6 M

Quarterly Volatility

27.5 M

Yuan Drop

Covid

Check PAVmed Series financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PAVmed Series' main balance sheet or income statement drivers, such as Interest Expense of 559.5 K, Selling General Administrative of 32.5 M or Other Operating Expenses of 74.8 M, as well as many indicators such as Price To Sales Ratio of 11.54, Dividend Yield of 3.0E-4 or Days Sales Outstanding of 14.05. PAVmed financial statements analysis is a perfect complement when working with PAVmed Series Valuation or Volatility modules.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Latest PAVmed Series' Total Assets Growth Pattern

Below is the plot of the Total Assets of PAVmed Series Z over the last few years. Total assets refers to the total amount of PAVmed Series assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in PAVmed Series Z books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. PAVmed Series' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PAVmed Series' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 33.12 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

PAVmed Total Assets Regression Statistics

	Arithmetic Mean	16,072,109
	Geometric Mean	4,308,251
	Coefficient Of Variation	155.82
	Mean Deviation	18,273,284
	Median	1,639,680
	Standard Deviation	25,042,866
	Sample Variance	627.1T
	Range	86.1M
	R-Value	0.66
	Mean Square Error	378.6T
	R-Squared	0.44
	Significance	0.01
	Slope	3,712,068
	Total Sum of Squares	8780T

PAVmed Total Assets History

	2024	23.6 M
	2023	33.1 M
	2022	54 M
	2021	87 M
	2020	19.8 M
	2019	7.2 M
	2018	8.5 M

Other Fundumenentals of PAVmed Series Z

Intangibles To Total Assets

PAVmed Series Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Capital Surpluse	Total Liab	Total Current Assets	Common Stock	Accounts Payable	Property Plant Equipment	Long Term Debt	Long Term Debt Total	Net Invested Capital	Net Working Capital	Short Long Term Debt	Capital Stock	Short Term Debt	Short Term Investments	Net Tangible Assets	Current Deferred Revenue	Net Receivables	Good Will	Intangible Assets
Total Assets		0.3	-0.58	-0.66	0.75	0.45	1.0	0.79	0.78	0.7	-0.66	-0.16	0.81	0.61	0.82	0.67	0.82	0.81	0.21	0.78	0.87	0.21	-0.43
Total Stockholder Equity	0.3		-0.94	0.51	-0.28	-0.7	0.38	0.47	0.1	-0.26	0.18	0.72	0.79	0.93	-0.23	-0.44	-0.23	-0.26	-0.74	-0.29	0.38	-0.74	0.7
Net Debt	-0.58	-0.94		-0.22	0.0	0.45	-0.65	-0.6	-0.31	0.01	0.04	-0.52	-0.92	-1.0	-0.08	0.17	-0.09	-0.04	0.52	-0.03	-0.65	0.52	-0.45
Retained Earnings	-0.66	0.51	-0.22		-0.92	-0.97	-0.6	-0.35	-0.66	-0.86	0.76	0.74	-0.11	0.18	-0.91	-0.96	-0.9	-0.92	-0.77	-0.91	-0.5	-0.77	0.92
Capital Surpluse	0.75	-0.28	0.0	-0.92		0.86	0.72	0.57	0.88	0.96	-0.91	-0.59	0.34	0.02	0.84	0.95	0.84	0.82	0.58	0.8	0.57	0.58	-0.72
Total Liab	0.45	-0.7	0.45	-0.97	0.86		0.39	0.2	0.56	0.8	-0.72	-0.8	-0.12	-0.42	0.78	0.93	0.78	0.81	0.8	0.8	0.27	0.8	-0.95
Total Current Assets	1.0	0.38	-0.65	-0.6	0.72	0.39		0.79	0.78	0.67	-0.64	-0.13	0.85	0.67	0.77	0.62	0.77	0.75	0.15	0.73	0.9	0.15	-0.35
Common Stock	0.79	0.47	-0.6	-0.35	0.57	0.2	0.79		0.8	0.57	-0.61	0.25	0.85	0.6	0.48	0.45	0.48	0.52	-0.26	0.38	0.47	-0.26	-0.16
Accounts Payable	0.78	0.1	-0.31	-0.66	0.88	0.56	0.78	0.8		0.86	-0.92	-0.21	0.61	0.31	0.64	0.73	0.64	0.62	0.19	0.56	0.57	0.19	-0.39
Property Plant Equipment	0.7	-0.26	0.01	-0.86	0.96	0.8	0.67	0.57	0.86		-0.88	-0.54	0.32	0.01	0.78	0.93	0.78	0.76	0.54	0.74	0.53	0.54	-0.67
Long Term Debt	-0.66	0.18	0.04	0.76	-0.91	-0.72	-0.64	-0.61	-0.92	-0.88		0.41	-0.37	-0.05	-0.67	-0.8	-0.67	-0.65	-0.41	-0.63	-0.46	-0.41	0.54
Long Term Debt Total	-0.16	0.72	-0.52	0.74	-0.59	-0.8	-0.13	0.25	-0.21	-0.54	0.41		0.35	0.48	-0.48	-0.63	-0.48	-0.49	-0.8	-0.55	-0.25	-0.8	0.74
Net Invested Capital	0.81	0.79	-0.92	-0.11	0.34	-0.12	0.85	0.85	0.61	0.32	-0.37	0.35		0.92	0.36	0.17	0.36	0.34	-0.36	0.28	0.72	-0.36	0.15
Net Working Capital	0.61	0.93	-1.0	0.18	0.02	-0.42	0.67	0.6	0.31	0.01	-0.05	0.48	0.92		0.11	-0.15	0.11	0.07	-0.5	0.06	0.68	-0.5	0.42
Short Long Term Debt	0.82	-0.23	-0.08	-0.91	0.84	0.78	0.77	0.48	0.64	0.78	-0.67	-0.48	0.36	0.11		0.9	1.0	0.97	0.68	0.99	0.68	0.68	-0.78
Capital Stock	0.67	-0.44	0.17	-0.96	0.95	0.93	0.62	0.45	0.73	0.93	-0.8	-0.63	0.17	-0.15	0.9		0.9	0.88	0.71	0.87	0.46	0.71	-0.85
Short Term Debt	0.82	-0.23	-0.09	-0.9	0.84	0.78	0.77	0.48	0.64	0.78	-0.67	-0.48	0.36	0.11	1.0	0.9		0.97	0.68	0.99	0.68	0.68	-0.78
Short Term Investments	0.81	-0.26	-0.04	-0.92	0.82	0.81	0.75	0.52	0.62	0.76	-0.65	-0.49	0.34	0.07	0.97	0.88	0.97		0.6	0.97	0.6	0.6	-0.86
Net Tangible Assets	0.21	-0.74	0.52	-0.77	0.58	0.8	0.15	-0.26	0.19	0.54	-0.41	-0.8	-0.36	-0.5	0.68	0.71	0.68	0.6		0.73	0.27	1.0	-0.75
Current Deferred Revenue	0.78	-0.29	-0.03	-0.91	0.8	0.8	0.73	0.38	0.56	0.74	-0.63	-0.55	0.28	0.06	0.99	0.87	0.99	0.97	0.73		0.68	0.73	-0.82
Net Receivables	0.87	0.38	-0.65	-0.5	0.57	0.27	0.9	0.47	0.57	0.53	-0.46	-0.25	0.72	0.68	0.68	0.46	0.68	0.6	0.27	0.68		0.27	-0.22
Good Will	0.21	-0.74	0.52	-0.77	0.58	0.8	0.15	-0.26	0.19	0.54	-0.41	-0.8	-0.36	-0.5	0.68	0.71	0.68	0.6	1.0	0.73	0.27		-0.75
Intangible Assets	-0.43	0.7	-0.45	0.92	-0.72	-0.95	-0.35	-0.16	-0.39	-0.67	0.54	0.74	0.15	0.42	-0.78	-0.85	-0.78	-0.86	-0.75	-0.82	-0.22	-0.75

Click cells to compare fundamentals

About PAVmed Series Financial Statements

PAVmed Series investors use historical fundamental indicators, such as PAVmed Series' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in PAVmed Series. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	33.1 M	23.6 M
Intangibles To Total Assets	0.04	0.03

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for PAVmed Stock Analysis

When running PAVmed Series' price analysis, check to measure PAVmed Series' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PAVmed Series is operating at the current time. Most of PAVmed Series' value examination focuses on studying past and present price action to predict the probability of PAVmed Series' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PAVmed Series' price. Additionally, you may evaluate how the addition of PAVmed Series to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC